Blood Cancer United secures remaining luveltamab tazevibulin supply to support children with rare AML, highlighting ongoing challenges in pediatric cancer drug funding.
- In the news
Biomedical Ethics and Regulation
Moving in Cancer Discovery.
- Moved this week
- 1
Rebuilt
Moved this week
Latest in Biomedical Ethics and Regulation
Newest first · last 60 days
Genomic and transcriptomic qualification of patient-derived dopaminergic neuron precursors was successfully achieved across multiple donors for Parkinson's disease therapy.
- Open access
Human pluripotent stem cell-derived dopaminergic progenitors are safe for transplantation in Parkinson's disease patients, with no serious adverse events observed over 12 months.
- Open access
Induced pluripotent stem cell technology has advanced from discovery to a promising clinical platform with early therapeutic trials and approvals.
Regulatory fragmentation creates significant challenges for SynBioxAI research, with ambiguities causing multiplicative friction across sixteen nations.
- Open access
Haploidentical stem cell transplantation is consistently more cost-effective than gene therapy for sickle cell disease, with a 100% probability across analyses.
Follow this area in the app
Browse JClub
Journals this month
- bioRxiv5569
- medRxiv1746
- Environ Res485
- PNAS463
- Sci Adv439
- JAMA255
- Cell Rep210
- BMJ205
- Nat Commun177
- Environ Pollution170
- Lancet149
- Science138
- NEJM119
- Applied & Environ Microbio116
- Curr Biol116
- J Exp Bot115
- mBio109
- Nature104
Moving areas, week to 3 Oct 2026
- Single-cell and spatial transcriptomics10
- Artificial Intelligence in Healthcare and Education8
- CAR-T cell therapy research7
- Neuroinflammation and Neurodegeneration Mechanisms6
- Lung Cancer Treatments and Mutations5
- Diabetes Treatment and Management4
- Pancreatic and Hepatic Oncology Research4
- Photosynthetic Processes and Mechanisms4
- Genomics and Chromatin Dynamics4
- Gut microbiota and health4